News & Views: Press releases
Promising news for patients with Parkinson’s Disease (PD) was reported at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases in Vienna earlier this month. PRX002/RG7935, currently in Phase 1b clinical trials, has been identified as having an acceptable safety profile and is expected to go into phase 2 clinical trials in the next few months.
The team at Porterhouse Medical is proud to have been given the ‘Highly Commended’ award at the Thames Valley Business Magazine’s 2016 Awards Ceremony last week, in the SME (Small and Medium-sized Enterprises) category.
We are delighted to announce that we have received Investors in People (IIP) accreditation at the Silver level. IIP accreditation is an internationally recognised and rigorously assessed performance framework that demonstrates a company’s commitment to staff training and development. Organisations that meet the world-recognised IIP Standard reflect the very best in people management excellence.
We are delighted and proud to announce that Porterhouse Medical has been recognized with the Queen’s Award for Enterprise 2016 – the UK’s highest accolade for outstanding achievement in business.